Cigna is looking to close its $52 billion acquisition of Express
Scripts and hopes that the deal will lower client expenses and
cushion the impact of increases in the cost of medical services.
In the third quarter, Cigna's commercial medical loss ratio -
the amount it spends on medical claims compared to income from
premiums in its biggest business - improved to 76.3 percent,
from 78.6 percent a year earlier.
The consensus estimate was 77.4 percent, according to brokerage
Evercore ISI.
Cigna, which mainly sells large and medium-sized corporate and
international insurance, said the commercial business saw a 3
percent rise in membership to 15.8 million.
"Results were driven in part by commercial customer growth,
expansion of specialty relationships and strong medical cost
performance," said Cantor Fitzgerald analyst Steven Halper.
Cigna, which also provides government-backed Medicare plans,
said it now expects full-year adjusted income from operations of
$14.20 to $14.40 per share.
The company had earlier forecast adjusted income from operations
to be in a range of $13.60 to $13.90 per share.
Net income for shareholders rose nearly 38 percent to $772
million, or $3.14 per share, in the third quarter ended Sept.
30.
Excluding items, Cigna earned $3.84 per share, above analysts'
average estimate of $3.44, according to Refinitiv data.
Operating revenue rose 10.3 percent to $11.46 billion, beating
estimate of $11.17 billion.
(Reporting by Manas Mishra and Tamara Mathias in Bengaluru;
Editing by Shailesh Kuber and Sriraj Kalluvila)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|